Navigation Links
Harborview Medical Center Implements Latest Release of the DocuSys Solution to Improve Anesthesia Medication Safety and Documentation

MOBILE, Ala. and SEATTLE, March 12 /PRNewswire/ -- DocuSys, Inc., a leading anesthesia information management system (AIMS) and medication management system provider, today announced that Harborview Medical Center in Seattle, Wash., the only Level I adult and pediatric trauma center serving a four-state region went live yesterday on DocuSys' anesthesia solutions, which will automate the documentation of anesthesia care and enhance the medication management processes in their perioperative (surgical) environment.

In support of its designation as a "Patient Safety Mentor Hospital" for other hospitals in the state of Washington, Harborview Medical Center chose to implement DocuSys' advanced medication safety solution including DocuJect(R), a point-of-care intravenous drug monitoring device, in addition to its AIMS application. DocuJect utilizes digital imaging and bar code scanning to proactively alert the clinician to potential adverse drug reactions. DocuSys' medication safety solutions are focused on enabling healthcare organizations to implement the recommendations outlined in last year's U.S. Pharmacopeia MEDMARX(R) Data Report to reduce perioperative medication error rates.

"We are committed to delivering the safest, most comprehensive anesthesia care to each of our patients, and the addition of the DocuSys solutions enables Harborview Medical Center to more effectively meet this objective," said Dr. Michael Souter, associate professor of Anesthesiology, Neurocritical Care, at Harborview Medical Center and anesthesiology project lead. "Having DocuSys share the anesthesiology record electronically with our electronic medical record system enables Harborview Medical Center to ensure continuity of care."

The ability to share clinical information among clinical system vendors has become a more important requirement over the past few years as healthcare organizations have made decisions to select a best-of-breed solution for key areas like anesthesiology. For Harborview Medical Center, the ability to integrate with their electronic medical record system was a key criterion in selecting DocuSys. According to DocuSys Executive Vice President and Chief Operating Officer, Joseph E. Heins, Pharm.D., the company has the broadest experience of any anesthesia information system vendor in providing this information in both a comprehensive anesthesia record format and as discrete data for key elements of the record.

"Harborview Medical Center is well known within Washington, as well as nationally, for delivering the best possible care to its patients," Heins said. "As the first client live on the latest release of our market-leading solutions, Harborview Medical Center worked closely with DocuSys to ensure the system was carefully configured to meet their advanced requirements. We are proud that Harborview Medical Center recognized the benefits of the DocuSys anesthesia solutions to enable them to augment their high standard of care."

About Harborview Medical Center

Founded in 1877, Harborview Medical Center is one of the region's most comprehensive healthcare facilities, providing high quality, technologically advanced care for everyone regardless of their ability to pay. Owned by King County and managed by the University of Washington, Harborview is the only Level I adult and pediatric trauma center and regional burn center serving the four-state region of Washington, Alaska, Montana and Idaho. In addition to being a "safety net" hospital providing care to the underserved, Harborview is the hospital of choice for many privately insured patients seeking a variety of services, such as neurosurgery, reconstruction and rehabilitation, and orthopedics. For more information, visit .

About DocuSys

DocuSys is a market-leading anesthesia information management system (AIMS) and medication management system provider, maximizing both the quality of care and return on investment in surgery. The company provides solutions that address all stage of the anesthesia care delivery process, including the preadmission evaluation process. Additional benefits of the system include ease of use, billing and charge capture automation and aligning such quality measures as CMS' pay-for-performance (P4P) program with financial objectives. DocuSys' modular design permits integration with existing hospital information systems, electronic medication dispensing cabinets, infusion pumps, physiologic monitors and other systems in those settings where intravenous drug delivery is key. The company has received 510(k) clearance from the Food and Drug Administration (FDA) to market its technology and is a registered medical device manufacturer in accordance with FDA guidelines. .

Contact: Tom Mitchell, Director of Marketing Communications


phone: (251)445-1651

SOURCE DocuSys, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MSU engineering team designs innovative medical device
2. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
4. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
5. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
6. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
7. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
8. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
9. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
10. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
11. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
Post Your Comments:
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin ... companies that call for a minimum wage raise to $12 an hour by 2020 and ... This will restore the lost value of the minimum wage, assure the wage floor does ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
Breaking Medicine Technology: